KERN logo

Akerna Corp. (KERN) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $0.31 ist Akerna Corp. (KERN) ein Healthcare-Unternehmen mit einer Bewertung von 163K. Bewertet mit 43/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 8. Feb. 2026
43/100 KI-Bewertung MCap 163K Vol 2M

Akerna Corp. (KERN) Gesundheitswesen & Pipeline-Uebersicht

CEOJessica Billingsley
Mitarbeiter112
HauptsitzDenver, CO, US
IPO-Jahr2018

Akerna Corp. is a leading provider of compliance and inventory management software for the cannabis industry, offering a comprehensive seed-to-sale platform and data analytics solutions, positioning it to capitalize on the expanding legal cannabis market in the US and Canada.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 8. Feb. 2026

Investmentthese

Akerna presents a notable research candidate due to its strategic positioning within the rapidly expanding legal cannabis market. The company's comprehensive seed-to-sale platform, coupled with its government regulatory software, provides a unique value proposition in a highly regulated industry. With a gross margin of 42.4%, Akerna demonstrates its ability to generate profitability from its software solutions. The increasing legalization of cannabis across North America serves as a significant growth catalyst, driving demand for Akerna's compliance and inventory management tools. While the company's negative P/E ratio of -15.93 and negative profit margin of -22.8% indicate current challenges, the potential for revenue growth in a burgeoning market, combined with operational efficiencies, could lead to improved financial performance and increased shareholder value.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Akerna operates in the rapidly growing cannabis, hemp, and CBD industry, poised for expansion as legalization efforts continue.
  • The company's MJ Platform offers a comprehensive seed-to-sale solution, addressing critical compliance and inventory management needs.
  • Leaf Data Systems provides government regulatory software, demonstrating Akerna's commitment to supporting regulatory compliance.
  • Akerna's gross margin of 42.4% indicates a strong ability to generate profit from its software solutions.
  • The company's beta of 2.79 suggests higher volatility compared to the overall market, reflecting the growth potential and risk associated with the cannabis industry.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Comprehensive seed-to-sale platform
  • Regulatory expertise and government software
  • Established customer base in the cannabis industry
  • Data analytics capabilities

Schwaechen

  • Negative P/E ratio and profit margin
  • High beta indicating volatility
  • Dependence on the cannabis industry
  • Limited geographic diversification

Katalysatoren

  • Upcoming: Further legalization of cannabis in additional states and countries, driving demand for compliance software.
  • Ongoing: Expansion of Akerna's product offerings to include new features and functionalities.
  • Ongoing: Strategic partnerships and acquisitions to expand market reach and product portfolio.

Risiken

  • Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.
  • Potential: Changes in cannabis regulations, requiring Akerna to adapt its software and services.
  • Potential: Economic downturn impacting cannabis businesses, reducing demand for Akerna's solutions.
  • Ongoing: Cybersecurity risks, potentially compromising customer data and disrupting operations.

Wachstumschancen

  • Expansion into New Geographies: As more states and countries legalize cannabis, Akerna has the opportunity to expand its operations into new markets. This expansion can be achieved through direct sales, partnerships, or acquisitions. The global legal cannabis market is projected to reach billions of dollars in the coming years, providing a substantial growth runway for Akerna.
  • Product Innovation and Development: Akerna can further enhance its product offerings by developing new features and functionalities for its MJ Platform and Leaf Data Systems. This includes incorporating advanced analytics, artificial intelligence, and machine learning to provide more insights and automation for its customers. Continuous innovation will help Akerna maintain its competitive edge and attract new customers.
  • Strategic Partnerships and Acquisitions: Akerna can pursue strategic partnerships and acquisitions to expand its product portfolio, geographic reach, and customer base. This includes partnering with other technology providers, cannabis industry consultants, and regulatory experts. Acquisitions can provide access to new technologies, markets, and talent.
  • Increased Focus on Data Analytics: Akerna can leverage its vast data resources to provide valuable insights and analytics to its customers. This includes offering customized reports, benchmarking data, and predictive analytics to help cannabis businesses optimize their operations, improve compliance, and increase profitability. Data analytics can become a significant revenue stream for Akerna.
  • Penetration of the Hemp and CBD Market: While Akerna has a presence in the hemp and CBD market, there is significant opportunity to further penetrate this segment. The hemp and CBD market is experiencing rapid growth, driven by increasing consumer awareness and demand for these products. Akerna can tailor its solutions to meet the specific needs of hemp and CBD businesses, capturing a larger share of this market.

Chancen

  • Expansion into new geographic markets
  • Product innovation and development
  • Strategic partnerships and acquisitions
  • Increased focus on data analytics

Risiken

  • Increasing competition in the cannabis software market
  • Changing cannabis regulations
  • Economic downturn impacting cannabis businesses
  • Cybersecurity risks

Wettbewerbsvorteile

  • Comprehensive Seed-to-Sale Platform: Akerna's MJ Platform offers a complete solution for tracking cannabis products from seed to sale, providing a competitive advantage over point solutions.
  • Regulatory Expertise: The company's deep understanding of cannabis regulations and its Leaf Data Systems software provide a barrier to entry for competitors.
  • Established Customer Base: Akerna has an established customer base in the cannabis industry, providing a recurring revenue stream and a competitive advantage.
  • Data Analytics Capabilities: Akerna's data analytics capabilities provide valuable insights to its customers, differentiating it from competitors.

Ueber KERN

Founded in 2010 and headquartered in Denver, Colorado, Akerna Corp. emerged as a key player in the burgeoning cannabis industry by providing essential software solutions. Recognizing the complex regulatory landscape and the need for efficient inventory management, Akerna developed the MJ Platform, a comprehensive seed-to-sale platform designed for cannabis, hemp, and CBD businesses. This platform offers tracking, reporting, and compliance tools crucial for cultivators, processors, sellers, and clinics. Akerna's commitment extends beyond commercial enterprises, as evidenced by Leaf Data Systems, a government regulatory software solution. This offering underscores Akerna's dedication to supporting regulatory compliance at all levels. The company further enhances its value proposition through consulting services tailored to the cannabis industry, along with business intelligence, data analytics, and other software-related services. Akerna also provides Last Call Analytics, a tool designed for alcohol brands to analyze their retail sales data. Akerna's comprehensive suite of solutions positions it as a vital partner for businesses navigating the complexities of the cannabis and related industries.

Was das Unternehmen tut

  • Provides seed-to-sale tracking software for the cannabis industry.
  • Offers regulatory compliance solutions for cannabis businesses.
  • Develops inventory management systems for cannabis cultivators, processors, and retailers.
  • Provides data analytics and business intelligence tools.
  • Offers consulting services to cannabis businesses.
  • Develops government regulatory software for cannabis tracking.
  • Provides solutions for the hemp and CBD industry.
  • Offers retail sales analytics for alcohol brands.

Geschaeftsmodell

  • Software as a Service (SaaS): Akerna generates revenue through recurring subscription fees for its MJ Platform and Leaf Data Systems.
  • Consulting Services: The company earns revenue from providing consulting services to cannabis businesses.
  • Data Analytics: Akerna generates revenue from providing data analytics and business intelligence services.
  • Software Related Services: The company earns revenue from other software related services.

Branchenkontext

Akerna operates within the medical and healthcare information services sector, specifically catering to the cannabis industry. The legal cannabis market is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. This growth necessitates robust compliance and inventory management solutions, creating a significant demand for Akerna's offerings. The competitive landscape includes companies like ATLN (Atlantic Coastal Healthcare Acquisition Corp), BLPH (BioLineRx Ltd), CMAX (CareMax Inc), HSTO (Histogen Inc), and HUGE (FSD Pharma Inc), some of which offer overlapping or complementary services. Akerna differentiates itself through its comprehensive seed-to-sale platform and government regulatory software.

Wichtige Kunden

  • Cannabis cultivators
  • Cannabis processors
  • Cannabis retailers
  • Cannabis clinics
  • Government regulatory bodies
KI-Zuversicht: 71% Aktualisiert: 8. Feb. 2026

Finanzdaten

Chart & Info

Akerna Corp. (KERN) Aktienkurs: $0.31 (+0.08, +36.94%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer KERN.

Kursziele

Wall-Street-Kurszielanalyse fuer KERN.

MoonshotScore

43/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von KERN auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Haeufige Fragen zu KERN

What are the key factors to evaluate for KERN?

Akerna Corp. (KERN) currently holds an AI score of 43/100, indicating low score. Key strength: Comprehensive seed-to-sale platform. Primary risk to monitor: Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.. This is not financial advice.

How frequently does KERN data refresh on this page?

KERN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven KERN's recent stock price performance?

Recent price movement in Akerna Corp. (KERN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive seed-to-sale platform. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider KERN overvalued or undervalued right now?

Determining whether Akerna Corp. (KERN) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying KERN?

Before investing in Akerna Corp. (KERN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding KERN to a portfolio?

Potential reasons to consider Akerna Corp. (KERN) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive seed-to-sale platform. Additionally: Regulatory expertise and government software. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of KERN?

Yes, most major brokerages offer fractional shares of Akerna Corp. (KERN) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track KERN's earnings and financial reports?

Akerna Corp. (KERN) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for KERN earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Stock data pending update. Financial data may be outdated.
Datenquellen

Popular Stocks